DB00398 ( Nexavar ) induces molecular remission and regression of extramedullary disease in a patient with P36888 -ITD+ acute myeloid leukemia . The fms-related tyrosine kinase 3 internal tandem duplication ( P36888 -ITD ) can be found in about one quarter of patients with acute myeloid leukemia ( AML ) [ Small D. P36888 mutations : biology and treatment. Hematology Am Soc Hematology. Educ. Program 2006;178-84 [ Review ] ] . Patients who carry this mutation have a high risk of relapse even after allogeneic stem cell transplantation [ Sheikhha MH , Awan A , Tobal K , Liu Yin JA . Prognostic significance of P36888 ITD and D835 mutations in AML patients. Hematol J 2003;4:41-6 ; Meshinchi S , Arceci RJ , Sanders JE , Smith FO , Woods WB , Radich JP , et al. Role of allogeneic stem cell transplantation in P36888 /ITD-positive AML . Blood 2006;108(1):400-1 ] . Recent reports show that DB00398 , a multikinase inhibitor has significant activity against P36888 -ITD(+) blasts in vitro [ Auclair D , Miller D , Yatsula V , Pickett W , Carter C , Chang Y , et al. Antitumor activity of sorafenib in P36888 -driven leukemic cells. Leukemia 2007;21(3):439-45 ] . We here report the first clinical case of molecular remission induced by DB00398 in a patient with P36888 -ITD(+) AML and extramedullary disease after allogenic stem cell transplantation .